GlassScriptPhysician profile
Lissette Ramirez
NPI 1780004150
$1,930.36
in general payments reported to CMS, 2019-2025
19 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $714 · 2023: $328 · 2024: $255 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $445.81 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $257.79 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $210.41 | 2021-2025 | Slynd |
| Mylan Pharmaceuticals INC. | $178.21 | 2021-2022 | |
| Daiichi Sankyo INC. | $146.62 | 2021-2022 | |
| Organon LLC | $134.08 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $93.31 | 2021-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $82.45 | 2022-2023 | |
| Astellas Pharma US INC | $79.62 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $55.30 | 2022 | |
| Pfizer INC. | $48.45 | 2022 | |
| Sage Therapeutics, LLC | $48.27 | 2024-2025 | Zurzuvae |
| Dexcom, INC. | $34.04 | 2025 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $30.68 | 2025 | Qelbree |
| Xeris Pharmaceuticals, INC. | $22.22 | 2023 | Gvoke Hypopen |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.84 | 2024 | Aptima |
| Baxter Healthcare | $16.78 | 2024 | Perclot |
| Evofem Biosciences, INC. | $14.02 | 2021 | |
| Exact Sciences Corporation | $13.46 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lissette Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.